AnalystsAlec Stranahan
Alec Stranahan's Stock Forecasts

Analyst Ranking
Bottom 2%
#5050 out of 5139 analysts
Average Return
-24.39%
Win Rate
42%11 out of 26
Risk vs Reward
Poor
Good

Alec Stranahan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Turning Point Therapeutics IncTPTX
+106.89%$36.74$76.01
2022-05-19 -
2022-08-16
Strong Buy
Revolution Medicines IncRVMD
+55.46%$28.38$44.12
2024-01-04 -
2025-01-03
Strong Buy
Krystal Biotech IncKRYS
+54.47%$151.90$234.64
2025-07-21 -
2025-12-09
Strong Buy
Krystal Biotech IncKRYS
+41.95%$117.53$166.83
2023-05-21 -
2024-05-21
Strong Buy
Hookipa Pharma IncHOOK
+41.33%$9.80$5.75
2022-12-01 -
2023-12-01
Sell

Alec Stranahan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Krystal Biotech IncKRYS
5Strong Buy$255.00+8.68%Maintains
2 months ago
Candel Therapeutics IncCADL
2Hold$7.00+23.67%Downgrades
3 months ago
Xencor IncXNCR
2Hold$12.00-28.61%Downgrades
3 months ago
Erasca IncERAS
3Sell$1.00-69.70%Downgrades
3 months ago
Novavax IncNVAX
4Sell$7.00+5.11%Downgrades
4 months ago
Beam Therapeutics IncBEAM
1Strong Buy$42.00+58.61%Upgrades
8 months ago
Y Mabs Therapeutics IncYMAB
5Hold$12.00+39.37%Maintains
9 months ago
Day One Biopharmaceuticals IncDAWN
5Strong Buy$25.00+203.03%Maintains
a year ago
Caribou Biosciences IncCRBU
1Strong Buy$11.00+488.24%Maintains
a year ago
Perspective Therapeutics IncCATX
2Hold$6.00N/ADowngrades
a year ago
Editas Medicine IncEDIT
1Strong Buy$15.00N/AUpgrades
a year ago
Revolution Medicines IncRVMD
3Strong Buy$55.00N/AMaintains
a year ago
Tg Therapeutics IncTGTX
2Sell$6.00N/AMaintains
3 years ago
Hookipa Pharma IncHOOK
1Sell$5.00N/ADowngrades
3 years ago
Springworks Therapeutics IncSWTX
1Strong Buy$45.00N/AInitiates Coverage On
3 years ago
Turning Point Therapeutics IncTPTX
1Strong Buy$58.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.